연구 & 소식

On the 21st, BioNutrition announced that a study confirmed the effectiveness of its Protein-Supplemented Very Low-Calorie Diet (PSVLCD) program, 

which includes its protein supplement, in managing obesity.

The study was published in the prominent international journal Frontiers in Nutrition (IF 4.0) and 

was evaluated to demonstrate the positive impact of a protein-supplemented very low-calorie diet on long-term weight loss, 

body composition improvement, and metabolic health enhancement.

Conducted in collaboration with Dietitian So-Hye Kim from Seoul National University Bundang Hospital and Professor Hwa-Jung Kim from Asan Medical Center,

 BioNutrition’s study involved 106 participants divided into a PSVLCD group and a traditional calorie-restricted diet group over a 12-month period.

The results showed that the PSVLCD group saw a significant improvement over the control group, 

with an average reduction of 8.35 cm in waist circumference and a decrease of 28.28 cm² in visceral fat area. 

Average weight loss in the PSVLCD group was 6.86 kg, compared to 4.66 kg in the control group, showing a meaningful difference.

BioNutrition’s program is considered valuable not only for weight reduction but also for maintaining muscle mass. 

Through the program, participants succeeded in reducing body fat while preserving muscle mass, and improving metabolic health markers 

such as blood pressure, fasting glucose, HbA1c, cholesterol, and triglycerides.

A representative from BioNutrition stated, 

“This study is the first randomized controlled trial conducted on Asians, 

providing robust evidence supporting tailored obesity treatment strategies that align with the dietary habits and obesity standards of populations in Korea and East Asia. 

Building on these results, 

we aim to develop sustainable weight-loss and metabolic health management programs for individuals with obesity and metabolic disorders.”